Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Oral Antigen
100%
Islet Cell Antibodies
100%
Prevention Trials
100%
Diabetes Prevention
100%
Type I Diabetes
100%
Glucose Tolerance Test
100%
Type 1 Diabetes Mellitus (T1DM)
100%
Recombinant Human Insulin
50%
Immune System Changes
50%
Systems Genetics
50%
Glutamic Acid
50%
Placebo-controlled
50%
Oral Glucose Tolerance Test
50%
Second-degree Relatives
50%
Recombinant Human
50%
Risk Degree
50%
Blood Test
50%
Blood Samples
50%
Patient Relatives
50%
Non-insulin-dependent Diabetes Mellitus (NIDDM)
50%
Control Intervention
50%
High Risk
50%
Low-dose Insulin
50%
Intermediate Risk
50%
Genetic Markers
50%
Treatment Phase
50%
Insulin Response
50%
Clinical Centers
50%
First Degree Relatives
50%
Prevention Study
50%
Diabetes Centres
50%
Medicine and Dentistry
Insulin Dependent Diabetes Mellitus
100%
Diabetes Prevention
100%
Volunteer
85%
Antigen
57%
Pancreas Islet Cell Antibody
28%
Glucose Test
28%
Oral
28%
Glutamic Acid
14%
Oral Glucose Tolerance Test
14%
Placebo
14%
Insulin Response
14%
Low Drug Dose
14%
Recombinant Human Insulin
14%
Diabetes
14%
Insulin
14%
Genetic Marker
14%
Immune System
14%
Nursing and Health Professions
Insulin Dependent Diabetes Mellitus
100%
Volunteer
85%
Antigen
57%
Pancreas Islet Cell Antibody
28%
Insulin
28%
Glucose Tolerance Test
28%
Oral Glucose Tolerance Test
14%
Microcapsule
14%
Glutamic Acid
14%
Treatment Phase
14%
Low Drug Dose
14%
Placebo
14%
Recombinant Human Insulin
14%